Literature DB >> 1334401

Attenuation of the systemic and coronary hemodynamic effects of cocaine in conscious dogs: propranolol versus labetalol.

D Kenny1, P S Pagel, D C Warltier.   

Abstract

The interaction of cocaine with myocardial and vascular adrenoceptors is incompletely understood. The systemic and coronary hemodynamic effects of intravenous cocaine (1.5 mg/kg) were examined in dogs with and without pretreatment with propranolol (2 mg/kg i.v.) or labetalol (5 mg/kg i.v.) on different days. A total of 24 experiments was completed (three sets of experiments) using eight dogs chronically instrumented for measurement of aortic and left-ventricular pressure, left-ventricular dP/dt, subendocardial segment length, coronary blood flow, and cardiac output. Myocardial oxygen consumption was estimated from the pressure work index (PWI). Cocaine significantly (p < 0.05) increased heart rate (+51 +/- 17 bpm), mean arterial pressure (+72 +/- 10 mm Hg), left-ventricular systolic and end-diastolic pressures (+56 +/- 9 and +14 +/- 6 mm Hg, respectively), coronary blood flow (+32 +/- 10 ml/min) and the PWI (+10.0 +/- 2.3 ml O2/min/100 g). Significant reductions in stroke volume (-9 +/- 5 ml) and percent segment shortening (-7.1 +/- 1.7) were observed. These changes returned to control after 30 min. After pretreatment with propranolol, the cocaine-mediated increases in mean arterial pressure, left-ventricular systolic pressure, rate-pressure product, and the pressure work index (4.4 +/- 0.7 ml O2/min/100 g) were significantly (p < 0.05) less than those observed with cocaine alone. Cocaine also reduced contractility [dP/dt50 (-341 +/- 80 mm Hg/s)] and increased systemic vascular resistance (+2703 +/- 339 dyn.s.cm-5) in the presence of propranolol. Labetalol abolished the cocaine-mediated increases in heart rate and coronary blood flow and significantly attenuated the increases in mean arterial pressure, left-ventricular systolic pressure, cardiac output, rate-pressure product, and calculated myocardial oxygen consumption when compared to results obtained with cocaine alone. The results demonstrate that a portion of the basic dynamic effects of cocaine is mediated by stimulation of alpha and beta adrenoceptors. Combined alpha and beta adrenergic blockade reduces the hemodynamic effects of cocaine more than beta blockade alone. During antagonism of the sympathomimetic response of cocaine, direct negative inotropic actions of this drug are unmasked.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1334401     DOI: 10.1007/bf00795059

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  33 in total

1.  Cocaine and cardiovascular function in dogs: effects on heart and peripheral circulation.

Authors:  J B Bedotto; R W Lee; L D Lancaster; M Olajos; S Goldman
Journal:  J Am Coll Cardiol       Date:  1988-06       Impact factor: 24.094

2.  Cocaine use in America: Introduction and overview.

Authors:  E H Adams; N J Kozel
Journal:  NIDA Res Monogr       Date:  1985

3.  Effect of cocaine on the coronary circulation and systemic hemodynamics in dogs.

Authors:  F E Kuhn; M N Johnson; R A Gillis; M S Visner; G L Schaer
Journal:  J Am Coll Cardiol       Date:  1990-11       Impact factor: 24.094

4.  Regional myocardial function during acute coronary artery occlusion and its modification by pharmacologic agents in the dog.

Authors:  P Theroux; D Franklin; J Ross; W S Kemper
Journal:  Circ Res       Date:  1974-12       Impact factor: 17.367

5.  Acute cocaine toxicity: antagonism by agents interacting with adrenoceptors.

Authors:  R W Derlet; T E Albertson
Journal:  Pharmacol Biochem Behav       Date:  1990-06       Impact factor: 3.533

6.  Effects of changes in preload, afterload and inotropic state on ejection and isovolumic phase measures of contractility in the conscious dog.

Authors:  F Mahler; J Ross; R A O'Rourke; J W Covell
Journal:  Am J Cardiol       Date:  1975-05       Impact factor: 2.778

7.  Electrocardiographic evidence for cocaine cardiotoxicity in cat.

Authors:  W J Crumb; P J Kadowitz; Y Q Xu; C W Clarkson
Journal:  Can J Physiol Pharmacol       Date:  1990-05       Impact factor: 2.273

8.  Intravenous cocaine infusions in humans: dose responsivity and correlations of cardiovascular vs. subjective effects.

Authors:  C Muntaner; K M Kumor; C Nagoshi; J H Jaffe
Journal:  Pharmacol Biochem Behav       Date:  1989-12       Impact factor: 3.533

9.  Mechanism of cocaine-induced myocardial depression in dogs.

Authors:  T D Fraker; P N Temesy-Armos; P S Brewster; R D Wilkerson
Journal:  Circulation       Date:  1990-03       Impact factor: 29.690

10.  Acute tolerance development to the cardiovascular and subjective effects of cocaine.

Authors:  M W Fischman; C R Schuster; J Javaid; Y Hatano; J Davis
Journal:  J Pharmacol Exp Ther       Date:  1985-12       Impact factor: 4.030

View more
  2 in total

Review 1.  Rethinking cocaine-associated chest pain and acute coronary syndromes.

Authors:  Jonathan B Finkel; Gregary D Marhefka
Journal:  Mayo Clin Proc       Date:  2011-12       Impact factor: 7.616

2.  Carvedilol Among Patients With Heart Failure With a Cocaine-Use Disorder.

Authors:  Dahlia Banerji; Raza M Alvi; Maryam Afshar; Noor Tariq; Adam Rokicki; Connor P Mulligan; Lili Zhang; Malek O Hassan; Magid Awadalla; John D Groarke; Tomas G Neilan
Journal:  JACC Heart Fail       Date:  2019-09       Impact factor: 12.035

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.